Fact CheckerSign in

NCT06954948Completed

Effect of Home-Based Pulmonary Rehabilitation

Effect of a Home-Based Pulmonary Rehabilitation on Patients' Outcome With COPD In Limited Recourses Country

Source: ClinicalTrials.gov · Last updated 25 Sept 2025

Brief summary (registry, in English)

This clinical trial aims to assess the effectiveness of home-based pulmonary rehabilitation in improving the clinical outcomes of patients with COPD. Research questions : RQ1: Is there a significant difference in the exacerbation rates before and after implementing the program? RQ2: Is there a significant improvement in the quality of life before and after implementing the program? RQ3: Is there a significant improvement in 6MWT before and after implementing the program? RQ4: Is there a significant improvement in COPD patients' modified Medical Research Council dyspnea scale before and after the implementation of the program? Intervention group will receive pulmonary rehabilitation at home or any place they designated over eight consecutive weeks. Two sessions per week and continuous phone calls. Participants will also be given a structured manual to record their activities and follow instructions on days without supervision. While the control group receive routine care at the respiratory unit.

Status (registry)
Completed
Study type
Interventional
Enrollment
128 (actual)
First submitted
10 Apr 2025
Start date
1 Sept 2024
Primary completion date
1 Mar 2025
Lead sponsor
Hawler Medical University
Diseases
COPD
NCT number
NCT06954948

What you commit to

  • Study type: Interventional
  • Participants enrolled: 128
  • From 1 Sept 2024 to the primary completion date, 1 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • patients with pulmonary hypertension
  • patients with movement disorders and/or a history of falls
  • patients with severe sensory or cognitive impairment
  • patients with symptomatic ischemic heart disease
  • patients with musculoskeletal degenerative disease

Other

  • Patients out site of the city or inability to be contacted

Who the study is looking for

  • Clinical diagnosis of COPD, confirmed by spirometry and pulmonologist
  • Age ≥40 years (to avoid recruiting participants with asthma rather than COPD)
  • Current or previous smoker (≥10 packs per year)
  • Confidence in using the proposed pulmonary rehabilitation (PR) system
  • Kurdish language fluency
  • Willingness to participate and sign an informed consent form.

Age in the registry: 40 years to 80 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hawler Medical University
Coordinator of this site? Confirm its status
ErbilIraqUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.